Fatal Aspiration Pneumonia as a Complication of Fecal Microbiota Transplant
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
To the Editor—Fecal microbiota transplant (FMT) is increasingly being used to treat refractory Clostridium difficile infection (CDI). The growing body of evidence indicates that the procedure is efficacious, with low rates of reported adverse events [1, 2]. Of 14 patients treated with FMT at our center, we report the first complication, highlighting the consequent changes to our practice. An 80-year-old patient with a past medical history of vasculopathy, osteoarthritis, and gout presented with recurrent CDI. The infection proved refractory to 3 courses of vancomycin, 2 of metronidazole, 1 of fidaxomicin, and 1 additional vancomycin course. Pseudomembranous colitis was confirmed on flexible sigmoidoscopy. In December 2013 radiologically guided insertion of a nasojejunal tube failed due to technical difficulties experienced when accessing the duodenum. An attempt to endoscopically place a nasojejunal tube was abandoned owing to epistaxis. In February 2014, the FMT was delivered to the distal duodenum via the biopsy channel of an enteroscope, on this occasion under general anesthesia. Using a 50-mL syringe, 100–150 mL of solution was instilled over 12 minutes. Feculent liquid was regurgitated during the third 50-mL aliquot and the procedure was terminated immediately. Initially physiologically stable, the patient's condition deteriorated in the subsequent hours, with pyrexia of 38.3°C, increasing oxygen requirements, and further vomiting. Renal function deteriorated from baseline urea of 9.9 mmol/L to 14.7 mmol/L and creatinine from baseline 102 µmol/L to 135 µmol/L. C reactive protein rose to 164 mg/L from 4 mg/L pre-procedure and white cell count fell to 3.5 × 109/L from 10 × 109/L. Chest X-ray showed left midzone airspace shadowing. Intravenous metronidazole was commenced and oral vancomycin continued. Computed tomography pulmonary angiogram (CTPA) excluded pulmonary embolus and confirmed widespread bilateral consolidation. During the next 48 hours the patient's condition worsened. Metronidazole was substituted by meropenem. Septic shock supervened, necessitating intensive care unit (ICU) admission for multiorgan support. Sputum culture isolated Escherichia coli and Pseudomonas aeruginosa. Blood cultures also isolated E. coli. Linezolid and fluconazole were added empirically. Once discharged to a medical ward 14 days later, a turbulent course ensued, with several episodes of sepsis necessitating 2 additional admissions to the ICU. Repeat blood cultures proved sterile throughout. CTPA was again negative for pulmonary embolus and confirmed persistent dense consolidation of the left lower lobe. Despite treatment at this time with meropenem and caspofungin, the patient died of pneumonia 48 days post FMT procedure. Stool samples tested negative for C. difficile glutamate dehydrogenase and toxin A/B (Techlab Quik Check Complete, Orlando, Florida) on days 4, 11, 13, and 42 post FMT. To our knowledge, this is the third reported death attributable to FMT; the others were due to toxic megacolon and septic shock [3] and to aspiration during sedation for colonoscopic FMT [4]. Our protocol now includes administration of an anti-emetic pre-procedure. General anesthetic is not common practice in FMT; therefore, the risk of aspiration peri-procedure may not be generalizable. We suggest that FMT via the upper gastrointestinal tract be performed only in the awake patient, with consideration of colonoscopic FMT when general anesthesia is required. Potential conflicts of interest. All authors: No potential conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kelly, C. R., Ihunnah, C., Fischer, M., Khoruts, A., Surawicz, C., Afzali, A., Aroniadis, O., Barto, A., Borody, T., Giovanelli, A., et al. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.133 · Cited by 636
Fecal Microbiota Transplantation: Indications, Methods, Evidence, and Future Directions
Borody, T. J., Paramsothy, S., & Agrawal, G. (2013) · Current Gastroenterology Reports · doi:10.1007/s11894-013-0337-1 · Cited by 275
Cited by
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
DeFilipp, Z., Bloom, P. P., Torres Soto, M., Mansour, M. K., Sater, M. R. A., Huntley, M. H., Turbett, S., Chung, R. T., Chen, Y.-B., & Hohmann, E. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1910437 · Cited by 1,281
European consensus conference on faecal microbiota transplantation in clinical practice
Cammarota, G., Ianiro, G., Tilg, H., Rajilić-Stojanović, M., Kump, P., Satokari, R., Sokol, H., Arkkila, P., Pintus, C., Hart, A., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313017 · Cited by 1,207
Kelly, C. R., Khoruts, A., Staley, C., Sadowsky, M. J., Abd, M., Alani, M., Bakow, B., Curran, P., McKenney, J., Tisch, A., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m16-0271 · Cited by 613
ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections
Kelly, C. R., Fischer, M., Allegretti, J. R., LaPlante, K., Stewart, D. B., Limketkai, B. N., & Stollman, N. H. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001278 · Cited by 579
Mullish, B. H., Quraishi, M. N., Segal, J. P., McCune, V. L., Baxter, M., Marsden, G. L., Moore, D. J., Colville, A., Bhala, N., Iqbal, T. H., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-316818 · Cited by 332
Self-citationMicrobiota transplantation: Concept, methodology and strategy for its modernization
FMT-standardization Study Group, Zhang, F., Cui, B., He, X., Nie, Y., Wu, K., & Fan, D. (2018) · Protein & Cell · doi:10.1007/s13238-018-0541-8 · Cited by 300
“Two deaths have been reported associated with FMT delivering procedures though mid-gut (Baxter et al., 2015; Goldenberg et al., 2018).”
BackgroundMarcella, C., Cui, B., Kelly, C. R., Ianiro, G., Cammarota, G., & Zhang, F. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16148 · Cited by 250
Dubberke, E. R., Lee, C. H., Orenstein, R., Khanna, S., Hecht, G., & Gerding, D. N. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy259 · Cited by 140
The role of gut microbiota in Clostridium difficile infection
Samarkos, M., Mastrogianni, E., & Kampouropoulou, O. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.02.006 · Cited by 75
“There have been cases of faecal aspiration and interestingly, one case of obesity, which developed after FMT from a healthy but overweight donor [66,67].”
Background
Metadata
- Authors
- Baxter, M., Ahmad, T., Colville, A., & Sheridan, R.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-03-24
- Volume
- 61
- Issue
- 1
- Pages
- 136-137
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2068375039
- Cited by
- 126
- References
- 2
- FWCI
- 9.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.